Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/17/2013

Company Name Symbol %Change
VIASAT INC VSAT
19.35%
OLD SECOND B OSBC
5.76%
GAMCO INVEST GBL
4.61%
CORNING INC GLW
4.47%
SYNCHRONOSS SNCR
4.23%
Zacks ZACKS.COM
PROFIT from the PROS

Tactics that Work in Good Markets and Bad
 
--

Dear Subscriber,

This will be the last big week for fourth-quarter earnings. Home Depot (HD), Target (TGT) and Dell (DELL) will all report. Find out which companies will surprise, and get details on the week's events, in Earnings Preview:

http://at.zacks.com/?id=3234

We also have additional insight from high-yield expert Carla Pasternak. Carla reveals an oddball security from Canada yielding 16%:

http://at.zacks.com/?id=3998

Wishing you prosperity,
Charles Rotblut, CFA
VP of Web Content & Editor,
Profit From the Pros

 

 

Today's Top Stories: Monday- February 23, 2009

ZACKS RANK BUY STOCKS

  • Aggressive Growth - ResMed Inc. (RMD) Earnings per share came in above expectations at 44 cents. Covering analysts were anticipating the company to post 42 cents per share. Read More...
     
  • Growth & Income - Steris Corporation (STE) has produced impressive surprises on earnings, topping analysts' EPS estimates by an average of 40% over the past 4 consecutive quarters. For the fiscal year ending March 2009, Wall Street is projecting EPS growth of 26% on a year-over-year basis. Read More...
     
  • Momentum - Treehouse Foods, Inc. (THS) After the solid quarter, analysts raised their earnings outlook, with the current-year estimate increasing 7 cents to $1.83 per share. The next-year estimate is pegged at $2.10, a 14.5% earnings growth projection. Read More...
     
  • Value - Encore Wire Corporation (WIRE) continues to outperform even while it customers operate in one of the toughest sectors in the economy: construction. On Feb 9, Encore beat Wall Street estimates for the fourth quarter by 69.82%. Read More...
     

Learn how to profit from our exclusive Zacks Rank stock-ranking system with free resources. Read More...


Sponsor

Private Zacks #1 Picks. Free with our Thanks.

Hand-picked stocks were recently added to our elite Timely Buys Portfolio, and we want valued members like you to share these market-beating picks without delay. See what Hulbert Financial Digest has rated #1 over the past 10 years. Claim these new picks free - Click here:

http://at.zacks.com/?id=5287


BEST OF ZACKS EQUITY RESEARCH

 


PERSONAL FINANCE: provided by Kiplinger.com

EDUCATION: Aggressive Growth.

Navigating IPO's. Read More...

PeopleAndPicks.com:

"TheInstitutional" is established with his BUY calls in DXD, TWM and UYG. Read More...

 

NEW ZACKS VIDEOS:

OTHER ZACKS RESOURCES:

 

Manage your Profit from the Pros subscription:

REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS!
http://at.zacks.com/?id=2311

Regards and Happy Investing,

Charles Rotblut, CFA
Senior Market Analyst
Zacks.com

p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here.

Visit /performance for information about the performance numbers displayed in this newsletter.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
111 N. Canal St., Suite 1101
Chicago, IL 60606

To unsubscribe from receiving "Zacks.com Profit from the Pros"
e-mail newsletter, Click here....

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.